NASDAQ

NervGen Pharma Corp. (NGEN)

♥ 692 Thanks from members

Live price chart, market sentiment, and community perspectives for NervGen Pharma Corp. (NASDAQ: NGEN).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Scientific FoundersLeadership: Paul Brennan (CEO)Leadership: Chadwick A. BriscoeHolder: ManagementHolder: Institutional InvestorsHolder: Specialized Biotech FundsNVG-291Nerve Repair TherapeuticsCentral Nervous System Treatments#NervGen Pharma#NGEN#Neurodegeneration#Nerve Repair#Biotech Stocks